{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T15:29:08Z","timestamp":1760887748997},"reference-count":80,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3744,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1196\/annals.1361.078","type":"journal-article","created":{"date-parts":[[2005,8,26]],"date-time":"2005-08-26T20:08:07Z","timestamp":1125086887000},"page":"362-371","source":"Crossref","is-referenced-by-count":18,"title":["Accelerated Atherosclerosis in Patients with Systemic Autoimmune Diseases"],"prefix":"10.1111","volume":"1051","author":[{"given":"KARINA","family":"LEEUW","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CEES","family":"KALLENBERG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MARC","family":"BIJL","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","reference":[{"key":"10.1196\/annals.1361.078-BIB1","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/hc0902.104353","article-title":"Inflammation and atherosclerosis","volume":"105","author":"Libby","year":"2002","journal-title":"Circulation"},{"key":"10.1196\/annals.1361.078-BIB2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis-an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1196\/annals.1361.078-BIB3","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1006\/jaut.2000.0393","article-title":"Heat shock protein 60\/65, beta 2-glycoprotein I and oxidized LDL as players in murine atherosclerosis","volume":"15","author":"Shoenfeld","year":"2000","journal-title":"J. Autoimmun."},{"key":"10.1196\/annals.1361.078-BIB4","first-page":"841","article-title":"Subclinical atherosclerosis in systemic lupus erythematosus","volume":"31","author":"Ahmad","year":"2004","journal-title":"J. Rheumatol."},{"key":"10.1196\/annals.1361.078-BIB5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/1529-0131(199901)42:1<51::AID-ANR7>3.0.CO;2-D","article-title":"Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus","volume":"42","author":"Manzi","year":"1999","journal-title":"Arthritis Rheum."},{"key":"10.1196\/annals.1361.078-BIB6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/art.11418","article-title":"Comparison of risk factors for vascular disease in the carotid artery and aorta in women with systemic lupus erythematosus","volume":"50","author":"Selzer","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1196\/annals.1361.078-BIB7","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1136\/ard.62.11.1071","article-title":"Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus Ann","volume":"62","author":"Doria","year":"2003","journal-title":"Rheum. Dis."},{"key":"10.1196\/annals.1361.078-BIB8","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1136\/ard.2004.029033","article-title":"Accelerated atherosclerosis in patients with Wegener's granulomatosis","volume":"64","author":"Leeuw","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1196\/annals.1361.078-BIB9","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1002\/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I","article-title":"Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus","volume":"44","author":"Esdaile","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1196\/annals.1361.078-BIB10","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1056\/NEJMoa035471","article-title":"Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus","volume":"349","author":"Roman","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1196\/annals.1361.078-BIB11","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/rheumatology\/keg182","article-title":"Atherosclerosis in premenopausal women with antiphospholipid syndrome and systemic lupus erythematosus: a controlled study","volume":"42","author":"Vlachoyiannopoulos","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1196\/annals.1361.078-BIB12","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0002-9343(76)90431-9","article-title":"The bimodal mortality pattern of systemic lupus erythematosus","volume":"60","author":"Urowitz","year":"1976","journal-title":"Am. J. Med."},{"key":"10.1196\/annals.1361.078-BIB13","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2249.1994.tb06107.x","article-title":"Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin during disease exacerbations in patients with systemic lupus erythematosus (SLE); a long term prospective study","volume":"97","author":"Spronk","year":"1994","journal-title":"Clin. Exp. Immunol."},{"key":"10.1196\/annals.1361.078-BIB14","first-page":"1228","article-title":"Serum levels of soluble adhesion molecules intercellular adhesion molecule 1, vascular cell adhesion molecule 1, and E-selectin in patients with Wegener's granulomatosis","volume":"37","author":"Stegeman","year":"1994","journal-title":"Relationship to disease activity and relevance during followup. Arthritis Rheum."},{"key":"10.1196\/annals.1361.078-BIB15","first-page":"376","article-title":"Up-regulation of endothelial cell adhesion molecules characterizes disease activity in systemic lupus erythematosus","volume":"37","author":"Belmont","year":"1994","journal-title":"The Shwartzman phenomenon revisited. Arthritis Rheum."},{"key":"10.1196\/annals.1361.078-BIB16","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1161\/hc4601.099485","article-title":"Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease","volume":"104","author":"Heitzer","year":"2001","journal-title":"Circulation"},{"key":"10.1196\/annals.1361.078-BIB17","first-page":"273","article-title":"Endothelial activation, endothelial dysfunction and premature atherosclerosis in systemic autoimmune diseases","volume":"61","author":"Bijl","year":"2003","journal-title":"Neth. J. Med."},{"key":"10.1196\/annals.1361.078-BIB18","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1136\/ard.62.2.162","article-title":"Diffuse endothelial dysfunction is common to ANCA associated systemic vasculitis and polyarteritis nodosa","volume":"62","author":"Filer","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"10.1196\/annals.1361.078-BIB19","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1161\/01.CIR.0000124720.18538.DD","article-title":"Infliximab improves endothelial dysfunction in systemic vasculitis: a model of vascular inflammation","volume":"109","author":"Booth","year":"2004","journal-title":"Circulation"},{"key":"10.1196\/annals.1361.078-BIB20","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/01.CIR.0000136807.78534.50","article-title":"Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women","volume":"110","author":"El-Magadmi","year":"2004","journal-title":"Circulation"},{"key":"10.1196\/annals.1361.078-BIB21","first-page":"292","article-title":"Brachial endothelial function is impaired in patients with systemic lupus erythematosus","volume":"29","author":"Lima","year":"2002","journal-title":"J. Rheumatol."},{"key":"10.1196\/annals.1361.078-BIB22","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1161\/01.CIR.102.13.1470","article-title":"Suppression of inflammation in primary systemic vasculitis restores vascular endothelial function: lessons for atherosclerotic disease","volume":"102","author":"Raza","year":"2000","journal-title":"Circulation"},{"key":"10.1196\/annals.1361.078-BIB23","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1161\/01.CIR.99.7.896","article-title":"Microvascular function relates to insulin sensitivity and blood pressure in normal subjects","volume":"99","author":"Serne","year":"1999","journal-title":"Circulation"},{"key":"10.1196\/annals.1361.078-BIB24","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.atherosclerosis.2003.11.015","article-title":"Non-invasive assessment of microvascular endothelial function by laser Doppler flowmetry in patients with essential hypertension","volume":"173","author":"Farkas","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1196\/annals.1361.078-BIB25","first-page":"433","article-title":"In vitro up-regulation of E-selectin and induction of interleukin-6 in endothelial cells by autoantibodies in Wegener's granulomatosis and microscopic polyangiitis","volume":"17","author":"Muller Kobold","year":"1999","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1196\/annals.1361.078-BIB26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.clim.2004.02.015","article-title":"Endothelial cell activation by antiphospholipid antibodies","volume":"112","author":"Meroni","year":"2004","journal-title":"Clin. Immunol."},{"key":"10.1196\/annals.1361.078-BIB27","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1177\/096120339600500521","article-title":"Antiphospholipid antibodies activate vascular endothelial cells","volume":"5","author":"Simantov","year":"1996","journal-title":"Lupus"},{"key":"10.1196\/annals.1361.078-BIB28","first-page":"727","article-title":"Antiendothelial cell antibodies in lupus: correlations with renal injury and circulating markers of endothelial damage","volume":"86","author":"Perry","year":"1993","journal-title":"Q. J. Med."},{"key":"10.1196\/annals.1361.078-BIB29","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJMoa021993","article-title":"Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events","volume":"347","author":"Ridker","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1196\/annals.1361.078-BIB30","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1161\/01.CIR.0000125527.41598.68","article-title":"Conformational rearrangement in C-reactive protein is required for proinflammatory actions on human endothelial cells","volume":"109","author":"Khreiss","year":"2004","journal-title":"Circulation"},{"key":"10.1196\/annals.1361.078-BIB31","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1161\/01.CIR.102.18.2165","article-title":"Direct proinflammatory effect of C-reactive protein on human endothelial cells","volume":"102","author":"Pasceri","year":"2000","journal-title":"Circulation"},{"key":"10.1196\/annals.1361.078-BIB32","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.20002","article-title":"Inflammation and arterial stiffness in systemic vasculitis: a model of vascular inflammation","volume":"50","author":"Booth","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1196\/annals.1361.078-BIB33","unstructured":"33Wick, G., M. Knoflach, M. Kind, et al. 2004. Heat shock proteins and stress in atherosclerosis. Autoimmun. Rev. 3 (Suppl. 1): S30-S31."},{"key":"10.1196\/annals.1361.078-BIB34","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1379\/1466-1268(1997)002<0094:CEOIVE>2.3.CO;2","article-title":"Co-expression of ICAM-1, VCAM-1, ELAM-1 and Hsp60 in human arterial and venous endothelial cells in response to cytokines and oxidized low-density lipoproteins","volume":"2","author":"Amberger","year":"1997","journal-title":"Cell Stress Chaperones"},{"key":"10.1196\/annals.1361.078-BIB35","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1172\/JCI5310","article-title":"Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages","volume":"103","author":"Kol","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1196\/annals.1361.078-BIB36","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1172\/JCI118320","article-title":"Autoantibodies against heat shock protein 60 mediate endothelial cytotoxicity","volume":"96","author":"Schett","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1196\/annals.1361.078-BIB37","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1161\/01.CIR.102.1.14","article-title":"Serum soluble heat shock protein 60 is elevated in subjects with atherosclerosis in a general population","volume":"102","author":"Xu","year":"2000","journal-title":"Circulation"},{"key":"10.1196\/annals.1361.078-BIB38","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1002\/art.20432","article-title":"Platelet-activating factor-acetylhydrolase and other novel risk and protective factors for cardiovascular disease in systemic lupus erythematosus","volume":"50","author":"Cederholm","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1196\/annals.1361.078-BIB39","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/art.20780","article-title":"Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations","volume":"52","author":"Frostegard","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1196\/annals.1361.078-BIB40","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1161\/hc4101.097518","article-title":"Risk factors for cardiovascular disease in systemic lupus erythematosus","volume":"104","author":"Svenungsson","year":"2001","journal-title":"Circulation"},{"key":"10.1196\/annals.1361.078-BIB41","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1038\/nm1102-1218","article-title":"Innate and acquired immunity in atherogenesis","volume":"8","author":"Binder","year":"2002","journal-title":"Nat. Med."},{"key":"10.1196\/annals.1361.078-BIB42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cccn.2004.05.021","article-title":"Antibodies to oxidized LDL in atherosclerosis development-clinical and animal studies","volume":"348","author":"Hulthe","year":"2004","journal-title":"Clin. Chim. Acta"},{"key":"10.1196\/annals.1361.078-BIB43","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.clim.2004.02.016","article-title":"Antiphospholipid antibodies and atherosclerosis","volume":"112","author":"Nicolo","year":"2004","journal-title":"Clin. Immunol."},{"key":"10.1196\/annals.1361.078-BIB44","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/S0891-5849(00)00333-6","article-title":"Immunological responses to oxidized LDL","volume":"28","author":"Horkko","year":"2000","journal-title":"Free Radic. Biol. Med."},{"key":"10.1196\/annals.1361.078-BIB45","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/nm0603-641","article-title":"Autoimmunity: busting the atherosclerotic plaque","volume":"9","author":"Rose","year":"2003","journal-title":"Nat. Med."},{"key":"10.1196\/annals.1361.078-BIB46","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/01.ATV.14.1.32","article-title":"Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL","volume":"14","author":"Yla-Herttuala","year":"1994","journal-title":"Arterioscler. Thromb."},{"key":"10.1196\/annals.1361.078-BIB47","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0140-6736(92)90926-T","article-title":"Autoantibody against oxidised LDL and progression of carotid atherosclerosis","volume":"339","author":"Salonen","year":"1992","journal-title":"Lancet"},{"key":"10.1196\/annals.1361.078-BIB48","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/0140-6736(93)91213-6","article-title":"Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus","volume":"341","author":"Vaarala","year":"1993","journal-title":"Lancet"},{"key":"10.1196\/annals.1361.078-BIB49","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1191\/096120399678847597","article-title":"Atherosclerosis-related markers in systemic lupus erythematosus patients: the role of humoral immunity in enhanced atherogenesis","volume":"8","author":"George","year":"1999","journal-title":"Lupus"},{"key":"10.1196\/annals.1361.078-BIB50","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1172\/JCI4533","article-title":"Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins","volume":"103","author":"Horkko","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1196\/annals.1361.078-BIB51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physrev.00048.2003","article-title":"Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture","volume":"85","author":"Newby","year":"2005","journal-title":"Physiol Rev."},{"key":"10.1196\/annals.1361.078-BIB52","first-page":"269","article-title":"Different expression of MMPs\/TIMP-1 in human atherosclerotic lesions","volume":"170","author":"Orbe","year":"2003","journal-title":"Relation to plaque features and vascular bed. Atherosclerosis"},{"key":"10.1196\/annals.1361.078-BIB53","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0735-1097(98)00250-2","article-title":"Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes","volume":"32","author":"Kai","year":"1998","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1196\/annals.1361.078-BIB54","first-page":"201","article-title":"Involvement of inflammation in acute coronary syndromes assessed by levels of high-sensitivity C-reactive protein, matrix metalloproteinase-9 and soluble vascular-cell adhesion molecule-1","volume":"42","author":"Nomoto","year":"2003","journal-title":"J. Cardiol."},{"key":"10.1196\/annals.1361.078-BIB55","first-page":"269","article-title":"Serum profiles of matrix metalloproteinases and their tissue inhibitor in patients with acute coronary syndromes","volume":"94","author":"Tziakas","year":"2004","journal-title":"The effects of short-term atorvastatin administration. Int. J. Cardiol."},{"key":"10.1196\/annals.1361.078-BIB56","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1161\/01.CIR.0000090689.69973.B1","article-title":"Matrix metalloproteinases as novel disease markers in Takayasu arteritis","volume":"108","author":"Matsuyama","year":"2003","journal-title":"Circulation"},{"key":"10.1196\/annals.1361.078-BIB57","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1002\/art.1780391019","article-title":"Elevated levels of 92-kd type IV collagenase (matrix metalloproteinase 9) in giant cell arteritis","volume":"39","author":"Sorbi","year":"1996","journal-title":"Arthritis Rheum."},{"key":"10.1196\/annals.1361.078-BIB58","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1136\/ard.61.2.161","article-title":"Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment","volume":"61","author":"Ribbens","year":"2002","journal-title":"Ann. Rheum. Dis."},{"key":"10.1196\/annals.1361.078-BIB59","first-page":"251","article-title":"Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1\/TIMP-1 complex in rheumatic disease","volume":"26","author":"Keyszer","year":"1999","journal-title":"Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers. J. Rheumatol."},{"key":"10.1196\/annals.1361.078-BIB60","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa035611","article-title":"Premature coronary-artery atherosclerosis in systemic lupus erythematosus","volume":"349","author":"Asanuma","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1196\/annals.1361.078-BIB61","first-page":"3947","article-title":"Systemic lupus erythematosus in a multiethnic US cohort (LUMINA)","volume":"50","author":"Toloza","year":"2004","journal-title":"XXIII. Baseline predictors of vascular events. Arthritis Rheum."},{"key":"10.1196\/annals.1361.078-BIB62","doi-asserted-by":"crossref","first-page":"764","DOI":"10.7326\/0003-4819-141-10-200411160-00007","article-title":"Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease","volume":"141","author":"Wei","year":"2004","journal-title":"Ann. Intern. Med."},{"key":"10.1196\/annals.1361.078-BIB63","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1093\/ndt\/13.7.1782","article-title":"Endothelium-dependent vasodilatation is impaired in peritoneal dialysis patients","volume":"13","author":"Guldener","year":"1998","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1196\/annals.1361.078-BIB64","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1001\/jama.281.19.1817","article-title":"Homocysteine and risk of cardiovascular disease among postmenopausal women","volume":"281","author":"Ridker","year":"1999","journal-title":"JAMA"},{"key":"10.1196\/annals.1361.078-BIB65","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1056\/NEJM199104253241701","article-title":"Hyperhomocysteinemia: an independent risk factor for vascular disease","volume":"324","author":"Clarke","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1196\/annals.1361.078-BIB66","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0140-6736(96)03032-2","article-title":"Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus","volume":"348","author":"Petri","year":"1996","journal-title":"Lancet"},{"key":"10.1196\/annals.1361.078-BIB67","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s100670200115","article-title":"Hyperhomocysteinaemia and risk of thrombosis in systemic lupus erythematosus patients","volume":"21","author":"Refai","year":"2002","journal-title":"Clin. Rheumatol."},{"key":"10.1196\/annals.1361.078-BIB68","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/BF03401819","article-title":"Elevated AGE-modified ApoB in sera of euglycemic, normolipidemic patients with atherosclerosis: relationship to tissue AGEs","volume":"3","author":"Stitt","year":"1997","journal-title":"Mol. Med."},{"key":"10.1196\/annals.1361.078-BIB69","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.cardiores.2004.05.001","article-title":"Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes","volume":"63","author":"Basta","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"10.1196\/annals.1361.078-BIB70","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1161\/01.RES.84.5.489","article-title":"Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis","volume":"84","author":"Schmidt","year":"1999","journal-title":"Circ. Res."},{"key":"10.1196\/annals.1361.078-BIB71","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1007\/BF00403914","article-title":"The role of glycation cross-links in diabetic vascular stiffening","volume":"39","author":"Sims","year":"1996","journal-title":"Diabetologia"},{"key":"10.1196\/annals.1361.078-BIB72","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.2174\/0929867043364342","article-title":"The clinical relevance of advanced glycation endproducts (AGE) and recent developments in pharmaceutics to reduce AGE accumulation","volume":"11","author":"Smit","year":"2004","journal-title":"Curr. Med. Chem."},{"key":"10.1196\/annals.1361.078-BIB73","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1161\/01.RES.0000137876.28454.64","article-title":"Protein glycation: a firm link to endothelial cell dysfunction","volume":"95","author":"Wautier","year":"2004","journal-title":"Circ. Res."},{"key":"10.1196\/annals.1361.078-BIB74","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/2012","article-title":"Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts","volume":"4","author":"Park","year":"1998","journal-title":"Nat. Med."},{"key":"10.1196\/annals.1361.078-BIB75","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1046\/j.1523-1755.2000.00117.x","article-title":"Mechanisms for the formation of glycoxidation products in end-stage renal disease","volume":"57","author":"Weiss","year":"2000","journal-title":"Kidney Int."},{"key":"10.1196\/annals.1361.078-BIB76","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1172\/JCI3042","article-title":"The myeloperoxidase system of human phagocytes generates Nepsilon-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation","volume":"104","author":"Anderson","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1196\/annals.1361.078-BIB77","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1056\/NEJMoa022287","article-title":"Circulating endothelial progenitor cells, vascular function, and cardiovascular risk","volume":"348","author":"Hill","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1196\/annals.1361.078-BIB78","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/hh1301.093953","article-title":"Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease","volume":"89","author":"Vasa","year":"2001","journal-title":"Circ. Res."},{"key":"10.1196\/annals.1361.078-BIB79","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1161\/01.CIR.0000082924.75945.48","article-title":"Aging, progenitor cell exhaustion, and atherosclerosis","volume":"108","author":"Rauscher","year":"2003","journal-title":"Circulation"},{"key":"10.1196\/annals.1361.078-BIB80","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1161\/01.CIR.0000039526.42991.93","article-title":"Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures","volume":"106","author":"Tepper","year":"2002","journal-title":"Circulation"}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1196%2Fannals.1361.078","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1196\/annals.1361.078\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T04:37:28Z","timestamp":1612499848000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1196\/annals.1361.078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,6]]}},"URL":"https:\/\/doi.org\/10.1196\/annals.1361.078","relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}